2026 ICD-10-CM Diagnosis Code Z12.72Encounter for screening for malignant neoplasm of vagina

ICD-10-CM Codes›Z00–Z99›Z00-Z13›Z12

ICD-10-CM Z12.72
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

Z12.72 is a billable ICD-10-CM diagnosis code for encounter for screening for malignant neoplasm of vagina. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. Coders also document this condition as sampling of vagina for Papanicolaou smear after hysterectomy for dysplasia of cervix done. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Neoplasm-related encounters.

Code Identity

ICD-10-CM Code
Z12.72
Billable Status
Yes — Valid for Submission
Code Describes
Encounter for screening for malignant neoplasm of vagina
Short Description
Encounter for screening for malignant neoplasm of vagina
Same as the full description in the CMS dataset.
Parent Code
Z12.7
Encounter for screening for malignant neoplasm of other genitourinary organs

Code Classification

ChapterZ00–Z99Factors influencing health status and contact with health services
SectionZ00-Z13Persons encountering health services for examinations
CategoryZ12Encounter for screening for malignant neoplasms
This CodeZ12.72Encounter for screening for malignant neoplasm of vagina

Code EditsBilling

Medicare Code Editor checks that affect claim validity for Z12.72.

Unacceptable principal diagnosis
There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)Billing

Z12.72 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Sampling of vagina for Papanicolaou smear after hysterectomy for dysplasia of cervix done
  • Screening for malignant neoplasm done
  • Screening for malignant neoplasm of vagina done
  • Screening for neoplasm done

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Vaginal pap smear status-post hysterectomy for non-malignant condition

Use Additional Code

  • code to identify acquired absence of uterus Z90.71

Type 1 Excludes

  • vaginal pap smear status-post hysterectomy for malignant conditions Z08

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Screening(for)
      • neoplasm (malignant) (of)
        • genitourinary organs NEC
          • vagina

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR FAC008
Neoplasm-related encounters
Default principal diagnosis: inpatient No · outpatient Yes

Patient EducationClinical

Health Screening

Screenings are tests that look for diseases before you have symptoms. Screening tests can find diseases early, when they're easier to treat. You can get some screenings in your doctor's office. Others need special equipment, so you may need to go to a different office or clinic.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert Z12.72 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
V76.47 Screen malig neop-vagina
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About Z12.72Overview

Is Z12.72 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report encounter for screening for malignant neoplasm of vagina on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

Can Z12.72 be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because encounter for screening for malignant neoplasm of vagina describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Is Z12.72 exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for encounter for screening for malignant neoplasm of vagina on inpatient claims.

What is the ICD-9 equivalent of Z12.72?

Under the General Equivalence Mappings, encounter for screening for malignant neoplasm of vagina converts to ICD-9-CM V76.47 (screen malig neop-vagina). The mapping is approximate, so confirm the match fits the documentation.